Register
Journal Updates
eMediNexus Coverage from: 
US FDA recalls several medicines containing valsartan following detection of an impurity
eMediNexus,  17 July 2018
remove_red_eye 713 Views
#Cardiology #Pharmacist #Public Health

0 Read Comments                

The US Food and Drug Administration (FDA) is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. However, not all products containing valsartan are being recalled.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!